Affiliation:
1. Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany University of Calcutta Kolkata India
2. School of Biological and Environmental Sciences, Shoolini University of Biotechnology and Management Sciences Solan India
3. California Department of Public Heath, Microbial Diseases Laboratory Richmond CA USA
Abstract
AbstractDermatomycosis or superficial mycosis is considered one of the chronic fungal infections and a global challenge for the public health system. The severity of dermatomycosis is proportionately increasing with the emerging population of immunocompromised individuals, and it is becoming more prevalent, even life‐threatening, in several tropical countries. In this context, improper long‐term treatment with synthetic antifungal drugs and their related side effects imposes additional challenges in treating dermatomycosis. Thus, the present scenario highlights the need for a novel and accurate treatment with minimal or no side effects. The multifaceted therapeutic properties of various natural products have garnered the interest of scientific communities in recent years. Generally, plant‐based products have low toxicity levels and offer diverse formulations and unique biomolecules for clinical applicability against dermatomycosis. Thus, this study presents an overview of the pathogenesis and different treatment strategies for dermatomycosis. In addition, we highlight the implementation of natural products of plant origin for treating dermatomycosis infections and reducing adverse events. Further, their mode of action and role in the development of pharmaceutical drugs are discussed.